Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To evaluate the safety and pharmacokinetics (PK) of up to 3 different dose schedules of panitumumab in pediatric subjects with solid tumors.
Critère d'inclusion
- Solid tumours
To evaluate the safety and pharmacokinetics (PK) of up to 3 different dose schedules of panitumumab in pediatric subjects with solid tumors.